NTRA250117C105000
- 63.62
- 0.000.00%
Natera Newsroom
Craig-Hallum Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $174
Craig-Hallum Sticks to Their Buy Rating for Natera (NTRA)
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Insider Sale: Director at $NTRA (NTRA) Sells 288 Shares
Natera Shares Are Trading Higher After Canaccord Genuity Raised Its Price Target on the Stock From $165 to $180.
Natera Is Maintained at Buy by Canaccord Genuity
CCORF Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $180
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Natera (NTRA) and Neumora Therapeutics, Inc. (NMRA)
Natera's (NASDAQ:NTRA) Investors Will Be Pleased With Their Enviable 353% Return Over the Last Five Years
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven?
Court Grants Natera's Request to Include Additional Patent in Its Lawsuit Against NeoGenomics
TD Cowen Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $195
Express News | Natera Inc : TD Cowen Raises Target Price to $195 From $175
Express News | Natera Inc : Guggenheim Raises Target Price to $170 From $165
Insider Sale: EXECUTIVE CHAIRMAN of $NTRA (NTRA) Sells 5,300 Shares
Natera(NTRA.US) Officer Sells US$26.52 Million in Common Stock
Express News | Form 144 | Natera(NTRA.US) Director Proposes to Sell 26.63 Million in Common Stocks
Natera Is Maintained at Overweight by JP Morgan
Natera Analyst Ratings
J.P. Morgan Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $200